U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 61 - 70 of 82 results

Status:
Possibly Marketed Outside US
First approved in 2013

Class:
POLYMER

structurally diverse
Status:
Other

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Previously Marketed
First approved in 2014

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Possibly Marketed Outside US
First approved in 2004

Class:
STRUCTURALLY DIVERSE

Status:
US Approved Rx (2015)
First approved in 2006

Class (Stereo):
CHEMICAL (RACEMIC)


Conditions:

Paliperidone (9-OH-risperidone) is the primary active metabolite of the older antipsychotic risperidone. While its specific mechanism of action is unknown, it is believed that paliperidone and risperidone act via similar if not the same pathways. It ...
Status:
US Approved Rx (2012)
First approved in 1970

Class (Stereo):
CHEMICAL (ABSOLUTE)



Clindamycin phosphate is the prodrug of clindamycin with no antimicrobial activity in vitro but can be rapidly converted in vivo to the parent drug, clindamycin, by phosphatase ester hydrolysis. It is indicated in the treatment of serious infections ...
Status:
US Approved Rx (2012)
First approved in 1970

Class (Stereo):
CHEMICAL (ABSOLUTE)



Clindamycin phosphate is the prodrug of clindamycin with no antimicrobial activity in vitro but can be rapidly converted in vivo to the parent drug, clindamycin, by phosphatase ester hydrolysis. It is indicated in the treatment of serious infections ...
Status:
US Approved Rx (2012)
First approved in 1970

Class (Stereo):
CHEMICAL (ABSOLUTE)



Clindamycin phosphate is the prodrug of clindamycin with no antimicrobial activity in vitro but can be rapidly converted in vivo to the parent drug, clindamycin, by phosphatase ester hydrolysis. It is indicated in the treatment of serious infections ...

Showing 61 - 70 of 82 results